531 related articles for article (PubMed ID: 19161833)
1. Therapeutic approaches to ion channel diseases.
Camerino DC; Desaphy JF; Tricarico D; Pierno S; Liantonio A
Adv Genet; 2008; 64():81-145. PubMed ID: 19161833
[TBL] [Abstract][Full Text] [Related]
2. Channels active in the excitability of nerves and skeletal muscles across the neuromuscular junction: basic function and pathophysiology.
Goodman BE
Adv Physiol Educ; 2008 Jun; 32(2):127-35. PubMed ID: 18539851
[TBL] [Abstract][Full Text] [Related]
3. Skeletal muscle channelopathies.
Jurkat-Rott K; Lerche H; Lehmann-Horn F
J Neurol; 2002 Nov; 249(11):1493-502. PubMed ID: 12420087
[TBL] [Abstract][Full Text] [Related]
4. Epilepsy and ionic channels.
Roll P; Szepetowski P
Epileptic Disord; 2002 Sep; 4(3):165-72. PubMed ID: 12446218
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiology and molecular pharmacology of muscle channelopathies.
Jurkat-Rott K; Lehmann-Horn F
Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S43-8. PubMed ID: 15269660
[TBL] [Abstract][Full Text] [Related]
6. Human skeletal muscle sodium channelopathies.
Vicart S; Sternberg D; Fontaine B; Meola G
Neurol Sci; 2005 Oct; 26(4):194-202. PubMed ID: 16193245
[TBL] [Abstract][Full Text] [Related]
7. Electromyography guides toward subgroups of mutations in muscle channelopathies.
Fournier E; Arzel M; Sternberg D; Vicart S; Laforet P; Eymard B; Willer JC; Tabti N; Fontaine B
Ann Neurol; 2004 Nov; 56(5):650-61. PubMed ID: 15389891
[TBL] [Abstract][Full Text] [Related]
8. Treatment in myotonia and periodic paralysis.
Meola G; Sansone V
Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S55-69. PubMed ID: 15269662
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune channelopathies.
Buckley C; Vincent A
Nat Clin Pract Neurol; 2005 Nov; 1(1):22-33. PubMed ID: 16932489
[TBL] [Abstract][Full Text] [Related]
10. Ion channel functional candidate genes in multigenic neuropsychiatric disease.
Gargus JJ
Biol Psychiatry; 2006 Jul; 60(2):177-85. PubMed ID: 16497276
[TBL] [Abstract][Full Text] [Related]
11. Genetic neurological channelopathies.
Hanna MG
Nat Clin Pract Neurol; 2006 May; 2(5):252-63. PubMed ID: 16932562
[TBL] [Abstract][Full Text] [Related]
12. Voltage-gated sodium channels: action players with many faces.
Koopmann TT; Bezzina CR; Wilde AA
Ann Med; 2006; 38(7):472-82. PubMed ID: 17101538
[TBL] [Abstract][Full Text] [Related]
13. Strategies to identify ion channel modulators: current and novel approaches to target neuropathic pain.
Birch PJ; Dekker LV; James IF; Southan A; Cronk D
Drug Discov Today; 2004 May; 9(9):410-8. PubMed ID: 15081958
[TBL] [Abstract][Full Text] [Related]
14. [Ion channels and penile erection].
Liu J; Chen J
Zhonghua Nan Ke Xue; 2004 Jun; 10(6):403-6, 410. PubMed ID: 15267199
[TBL] [Abstract][Full Text] [Related]
15. Channelopathies: episodic disorders of the nervous system.
Ptacek L
Novartis Found Symp; 2002; 241():87-104; discussion 104-8, 226-32. PubMed ID: 11771653
[TBL] [Abstract][Full Text] [Related]
16. Ion channel modulators: new targets and new indications for old targets.
Priest B; Kaczorowski GJ; Garcia ML
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):587-94. PubMed ID: 17002219
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic scope of modulation of non-voltage-gated cation channels.
Li S; Gosling M; Poll CT; Westwick J; Cox B
Drug Discov Today; 2005 Jan; 10(2):129-37. PubMed ID: 15718162
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic scope of modulation of non-voltage-gated cation channels.
Li S; Gosling M; Poll CT; Westwick J; Cox B
Drug Discov Today; 2004 Dec; 9(24):1045-54. PubMed ID: 15582793
[TBL] [Abstract][Full Text] [Related]
19. Voltage-sensitive ion channels and cancer.
Fiske JL; Fomin VP; Brown ML; Duncan RL; Sikes RA
Cancer Metastasis Rev; 2006 Sep; 25(3):493-500. PubMed ID: 17111226
[TBL] [Abstract][Full Text] [Related]
20. Pathomechanisms in channelopathies of skeletal muscle and brain.
Cannon SC
Annu Rev Neurosci; 2006; 29():387-415. PubMed ID: 16776591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
